Produção Nacional
Revisado por pares
Guidelines on the Diagnosis and Treatment of Hypertrophic Cardiomyopathy - 2024
2024; Sociedade Brasileira de Cardiologia (SBC); Volume: 121; Issue: 7 Linguagem: Inglês
10.36660/abc.20240415i
ISSN1678-4170
AutoresFábio Fernandes, Marcus Vinı́cius Simões, Edileide de Barros Correia, Fabiana G. Marcondes‐Braga, Otávio R. Coelho‐Filho, Cláudio Tinoco Mesquita, Wilson Mathias, Murillo de Oliveira Antunes, Edmundo Arteaga-Fernández, Carlos Eduardo Rochitte, Félix José Alvarez Ramires, Sílvia Marinho Martins Alves, Marcelo Westerlund Montera, Renato D. Lópes, Múcio Tavares de Oliveira, Fernando Luís Scolari, Walkíria Samuel Ávila, Manoel Fernandes Canesin, Edimar Alcides Bocchi, Fernando Bacal, Lídia Zytynski Moura, Eduardo Saad, Maurício Scanavacca, Bruno Pereira Valdigem, M N Cano, Alexandre Abizaid, Henrique Barbosa Ribeiro, Pedro A. Lemos, Gustavo Calado de Aguiar Ribeiro, Fábio Biscegli Jatene, Ricardo Ribeiro Dias, Luís Beck da Silva Neto, Luís Eduardo Paim Rohde, Marcelo Imbroinise Bittencourt, Alexandre C. Pereira, José Eduardo Krieger, Humberto Villacorta, Wolney de Andrade Martins, José Albuquerque de Figueiredo Neto, Juliano Novaes Cardoso, Carlos Alberto Pastore, Ieda Biscegli Jatene, A. Tanaka, Viviane Tiemi Hotta, Minna Moreira Dias Romano, Denílson Campos de Albuquerque, Ricardo Mourilhe‐Rocha, Ludhmila Abrahão Hajjar, Fábio Sândoli de Brito, Bruno Caramelli, Daniela Calderaro, Pedro Sílvio Farsky, Alexandre Siciliano Colafranceschi, Ibraim Pinto, Marcelo Luiz Campos Vieira, Luiz Cláudio Danzmann, Sílvio Henrique Barberato, Charles Mady, Martino Martinelli Filho, Ana Flávia Malheiros Torbey, Pedro Vellosa Schwartzmann, Ariane Vieira Scarlatelli Macedo, Silvia Moreira Ayub‐Ferreira, André Schmidt, Marcelo Dantas Tavares de Melo, Moysés de Oliveira Lima-Filho, Andrei C. Spósito, Flávio de Souza Brito, Andréia Biolo, Vagner Madrini, Stéphanie Itala Rizk, Evandro Tinoco Mesquita,
Tópico(s)Cardiovascular Effects of Exercise
Resumo1. Introduction Scientific knowledge of hypertrophic cardiomyopathy (HCM) has significantly improved in the past decades. A better understanding of its pathogenesis, significant advances in the use of imaging methods, and the more common application of genetic analysis, in addition to a better characterization of the natural history of this myocardial disease, have profoundly reformulated its clinical and prognostic significance. Conversely, these processes were accompanied by the development of new medications addressing molecular mechanisms intrinsically linked to the pathophysiology and pathogenesis [...]
Referência(s)